SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

被引:151
作者
Shen, Xiaoying [1 ,2 ]
Tang, Haili [1 ]
McDanal, Charlene [1 ]
Wagh, Kshitij [3 ]
Fischer, William [3 ]
Theiler, James [3 ]
Yoon, Hyejin [3 ]
Li, Dapeng [2 ]
Haynes, Barton F. [2 ,6 ]
Sanders, Kevin O. [1 ,2 ]
Gnanakaran, Sandrasegaram [3 ]
Hengartner, Nick [3 ]
Pajon, Rolando [4 ]
Smith, Gale [5 ]
Glenn, Gregory M. [5 ]
Korber, Bette [3 ]
Montefiori, David C. [1 ,2 ]
机构
[1] Duke Univ, Dept Surg, Sch Med, Durham, NC 27708 USA
[2] Duke Univ, Duke Human Vaccine Inst, Sch Med, Durham, NC 27708 USA
[3] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM USA
[4] Moderna Inc, Cambridge, MA USA
[5] Novavax Inc, Gaithersburg, MD USA
[6] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
VIVO;
D O I
10.1016/j.chom.2021.03.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of generating protective neutralizing antibodies. The recent emergence and rapid spread of several SARS-CoV-2 variants carrying multiple spike mutations raise concerns about possible immune escape. One variant, first identified in the United Kingdom (B.1.1.7, also called 20I/501Y.V1), contains eight spike mutations with potential to impact antibody therapy, vaccine efficacy, and risk of reinfection. Here, we show that B.1.1.7 remains sensitive to neutralization, albeit at moderately reduced levels (similar to sim;2-fold), by serum samples from convalescent individuals and recipients of an mRNA vaccine (mRNA-1273, Moderna) and a protein nanoparticle vaccine (NVX-CoV2373, Novavax). A subset of monoclonal antibodies to the receptor binding domain (RBD) of spike are less effective against the variant, while others are largely unaffected. These findings indicate that variant B.1.1.7 is unlikely to be a major concern for current vaccines or for an increased risk of reinfection.
引用
收藏
页码:529 / +
页数:14
相关论文
共 55 条
[1]   Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults [J].
Anderson, E. J. ;
Rouphael, N. G. ;
Widge, A. T. ;
Jackson, L. A. ;
Roberts, P. C. ;
Makhene, M. ;
Chappell, J. D. ;
Denison, M. R. ;
Stevens, L. J. ;
Pruijssers, A. J. ;
McDermott, A. B. ;
Flach, B. ;
Lin, B. C. ;
Doria-Rose, N. A. ;
O'Dell, S. ;
Schmidt, S. D. ;
Corbett, K. S. ;
Swanson, P. A., II ;
Padilla, M. ;
Neuzil, K. M. ;
Bennett, H. ;
Leav, B. ;
Makowski, M. ;
Albert, J. ;
Cross, K. ;
Edara, V. V. ;
Floyd, K. ;
Suthar, M. S. ;
Martinez, D. R. ;
Baric, R. ;
Buchanan, W. ;
Luke, C. J. ;
Phadke, V. K. ;
Rostad, C. A. ;
Ledgerwood, J. E. ;
Graham, B. S. ;
Beigel, J. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2427-2438
[2]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[3]   SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies [J].
Barnes, Christopher O. ;
Jette, Claudia A. ;
Abernathy, Morgan E. ;
Dam, Kim-Marie A. ;
Esswein, Shannon R. ;
Gristick, Harry B. ;
Malyutin, Andrey G. ;
Sharaf, Naima G. ;
Huey-Tubman, Kathryn E. ;
Lee, Yu E. ;
Robbiani, Davide F. ;
Nussenzweig, Michel C. ;
West, Anthony P., Jr. ;
Bjorkman, Pamela J. .
NATURE, 2020, 588 (7839) :682-+
[4]   Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies [J].
Baum, Alina ;
Fulton, Benjamin O. ;
Wloga, Elzbieta ;
Copin, Richard ;
Pascal, Kristen E. ;
Russo, Vincenzo ;
Giordano, Stephanie ;
Lanza, Kathryn ;
Negron, Nicole ;
Ni, Min ;
Wei, Yi ;
Atwal, Gurinder S. ;
Murphy, Andrew J. ;
Stahl, Neil ;
Yancopoulos, George D. ;
Kyratsous, Christos A. .
SCIENCE, 2020, 369 (6506) :1014-+
[5]   Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type [J].
Biswas, Nidhan K. ;
Majumder, Partha P. .
INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 151 (05) :450-458
[6]   Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability [J].
Brouwer, Philip J. M. ;
Caniels, Tom G. ;
van der Straten, Karlijn ;
Snitselaar, Jonne L. ;
Aldon, Yoann ;
Bangaru, Sandhya ;
Torres, Jonathan L. ;
Okba, Nisreen M. A. ;
Claireaux, Mathieu ;
Kerster, Gius ;
Bentlage, Arthur E. H. ;
van Haaren, Marlies M. ;
Guerra, Denise ;
Burger, Judith A. ;
Schermer, Edith E. ;
Verheul, Kirsten D. ;
van der Velde, Niels ;
van der Kooi, Alex ;
van Schooten, Jelle ;
van Breemen, Marielle J. ;
Bijl, Tom P. L. ;
Sliepen, Kwinten ;
Aartse, Aafke ;
Derking, Ronald ;
Bontjer, Ilja ;
Kootstra, Neeltje A. ;
Wiersinga, W. Joost ;
Vidarsson, Gestur ;
Haagmans, Bart L. ;
Ward, Andrew B. ;
de Bree, Godelieve J. ;
Sanders, Rogier W. ;
van Gils, Marit J. .
SCIENCE, 2020, 369 (6504) :643-+
[7]   NOVAVAX OFFERS FIRST EVIDENCE THAT COVID VACCINES PROTECT PEOPLE AGAINST VARIANTS [J].
Callaway, Ewen ;
Mallapaty, Smriti .
NATURE, 2021, 590 (7844) :17-17
[8]  
Carabelli, 2021, RECURRENT EMERGENCE, DOI 10.1101/2020.12.14.422555
[9]   A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 [J].
Chi, Xiangyang ;
Yan, Renhong ;
Zhang, Jun ;
Zhang, Guanying ;
Zhang, Yuanyuan ;
Hao, Meng ;
Zhang, Zhe ;
Fan, Pengfei ;
Dong, Yunzhu ;
Yang, Yilong ;
Chen, Zhengshan ;
Guo, Yingying ;
Zhang, Jinlong ;
Li, Yaning ;
Song, Xiaohong ;
Chen, Yi ;
Xia, Lu ;
Fu, Ling ;
Hou, Lihua ;
Xu, Junjie ;
Yu, Changming ;
Li, Jianmin ;
Zhou, Qiang ;
Chen, Wei .
SCIENCE, 2020, 369 (6504) :650-+
[10]  
DAVIES NG, 2020, ESTIMATED TRANSMISSI, DOI [DOI 10.1101/2020.12.24.20248822, 10.1126/science.abg3055]